3 unknown, 2 completed, 1 not yet recruiting. 6 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Unknown 3, Completed 2, Not yet recruiting 1 |
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
Follow ivarmacitinib: new trials by email Literature Review of ivarmacitinib trials Research Report on ivarmacitinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ivarmacitinib Versus Glucocorticoids in Mild-to-Moderate Systemic Lupus Erythematosus Ivarmacitinib Sulfate Tablets, Prednisone Acetate Tablets - Systemic Lupus Erthematosus | Phase 2 / Phase 3 | Not yet recruiting | Chinese SLE Treatment And Research Group | 294 | 2026-10-15 | 2026-09-11 |
| A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Non-Radiographic Axial Spondyloarthritis SHR0302, SHR0302 placebo - Non-radiographic Axial Spondyloarthritis | Phase 3 | Unknown | Jiangsu HengRui Medicine Co., Ltd. | 300 | 2022-08-16 | 2022-09-02 |
| Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata SHR0302, Placebo - Alopecia Areata | Phase 3 | Unknown | Reistone Biopharma Company Limited | 330 | 2022-04-18 | 2023-09-05 |
| A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis SHR0302, Placebo - Ulcerative Colitis | Phase 3 | Unknown | Reistone Biopharma Company Limited | 368 | 2021-11-05 | 2023-09-05 |
| A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Ankylosing Spondylitis SHR0302, SHR0302 placebo - Ankylosing Spondylitis | Phase 2 / Phase 3 | Completed | Jiangsu HengRui Medicine Co., Ltd. | 504 | 2020-10-14 | 2023-07-27 |
| A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Rheumatoid Arthritis SHR0302, Placebo - Rheumatoid Arthritis | Phase 3 | Completed | Jiangsu HengRui Medicine Co., Ltd. | 566 | 2020-07-31 | 2023-11-22 |
Alopecia Areata (1) · Arthritis, Rheumatoid (1) · Colitis, Ulcerative (1) · Non-Radiographic Axial Spondyloarthritis (1) · Spondylitis, Ankylosing (1)
Jiangsu HengRui Medicine Co., Ltd. (3) · Reistone Biopharma Company Limited (2) · Chinese SLE Treatment And Research Group (1)
China (6) · Georgia (1) · Poland (1) · Ukraine (1) · United States (1)
Xiang Chen (1)